NOVEMBER 2022LIFE SCIENCES REVIEW6This year, the clinical trials sector witnessed an overwhelming trend in the adoption of various technologies. Decentralised and hybrid designs and blockchain technology have increased patient access and reduced the need to travel for in-person assessments. These innovations in trial designs have helped overcome numerous challenges, particularly around patient recruitment and drug development costs. Recent technological advancements in clinical trials have resulted in a positive impact on the European market. A significant amount of research funding from public sector organizations is driving the demand for personalised medicines in the region.This edition of Life Sciences Review Europe brings the spotlight to the key developments in the clinical trials space and presents the list of the Top 10 Clinical Trial Management Solution providers in Europe and the Top 5 Clinical Trial Management Solution Providers in the UK. Komtur and Clinical Net are companies that make clinical trial participation more convenient, ultimately leading to the anticipated approval of new therapies for humankind. Komtur is a company that renders an unrivalled global import, export, and distribution service for controlled drugs. Clinical Net on the other hand is a UK health tech startup focused on the development of a centralised clinical trial platform designed to share clinical trial information, and automate processes to accelerate clinical drug development.We also bring to you thought leadership articles and exclusive insights from expert CIOs and CXOs- Caroline Herody, Head of Global Regulatory Affairs, Chr. Hansen, Chris Dobbs, CEng MIET, Head of Technical Engineering, PCI Pharma Services, Philippe Pinton, SVP, Global Head Translational Medicine and Clinical Pharmacology, Ferring Pharmaceuticals expressing their ideas on how to digitalise clinical trial processes to facilitate access for patients, improve trial recruitment and success rate, and ultimately reduce costs and accelerate time associated with drug development. We hope the valuable insights from industry thought leaders featured in this edition help you make informed decisions for your organisation.Let us know your thoughts!EDITORIALThe Changing Face of Clinical Trial ManagementCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasGilbert HooverAncel CastelinoDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsNovember - 28 - 2022, Vol 03, Issue - 04 (ISSN 2831-8323) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com VisualizersRonald DonovanVictor Cruz Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com
< Page 5 | Page 7 >